Alternatively, given that both NQO2 and PTEN can negatively regulate PI3K/AKT pathway via control of the interaction between AKT and its activator PIP3, an increase in NQO2 expression could restrict proliferation and survival of PTEN-deficient cancer cells by amplifying sensitivity to chemotherapeutic agents. This evidence concerns the gene PTEN and cancer.